Harbour Trust & Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Sell
3,809
-51
-1% -$17.5K 0.13% 73
2026
Q1
$1.36M Sell
3,860
-145
-4% -$51.7K 0.14% 75
2025
Q4
$1.31M Sell
4,005
-539
-12% -$171K 0.13% 74
2025
Q3
$1.28M Sell
4,544
-151
-3% -$43.8K 0.13% 79
2025
Q2
$1.31M Sell
4,695
-14
-0.3% -$3.97K 0.15% 79
2025
Q1
$1.47M Sell
4,709
-218
-4% -$64.4K 0.18% 75
2024
Q4
$1.28M Sell
4,927
-108
-2% -$32K 0.15% 80
2024
Q3
$1.62M Buy
5,035
+57
+1% +$18.6K 0.18% 78
2024
Q2
$1.56M Buy
4,978
+15
+0.3% +$4.41K 0.19% 78
2024
Q1
$1.41M Buy
4,963
+19
+0.4% +$5.56K 0.18% 84
2023
Q4
$1.42M Buy
+4,944
New +$1.35M 0.2% 82

Other funds holding AMGN

Harbour Trust & Investment Management's AMGN Position: Q2 2026 in Review

Harbour Trust & Investment Management reduced its Amgen (AMGN) stake by 1.3% in Q2 2026, selling an estimated $17.5K and leaving 3,809 shares worth $1.38M. The position accounts for 0.13% of the portfolio, ranked #73.

Harbour Trust & Investment Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.62M in Q3 2024. 1,540 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Harbour Trust & Investment Management held 3,809 shares of Amgen worth $1.38M as of Q2 2026.
  • Harbour Trust & Investment Management sold 51 Amgen shares in Q2 2026, an estimated $17.5K.
  • Amgen made up 0.13% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #73 holding.
  • Harbour Trust & Investment Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Harbour Trust & Investment Management's Amgen position peaked at $1.62M in Q3 2024.
  • 1,540 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.